Tirzepatide Sodium Overview

Tirzepatide sodium, a peptide for treating type 2 diabetes, functions by mimicking the effects of incretin hormones GLP-1 and GIP. These hormones stimulate insulin release, reduce glucagon secretion, and slow gastric emptying. Used for improving blood sugar control in adults with type 2 diabetes, Tirzepatide also aids in weight loss. Administered via subcutaneous injection, it represents a significant advancement in type 2 diabetes management with its dual-action mechanism.

Product Details

• Amino Acid Sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS
• Note: Aib is a non-coded (non-proteinogenic) amino acid – H₂H-C(CH₃)₂-COOH
• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.527 g/mol
• PubChem CID: 156588324
• CAS Number: 2023788-19-2

Research Highlights

1. Blood Glucose Control: Tirzepatide effectively regulates blood glucose levels through dual agonism of GIP and GLP-1 receptors, crucial for insulin secretion and post-meal blood sugar management.
2. Cardiovascular Benefits: Demonstrates the ability to improve cardiovascular health by lowering blood pressure and reducing levels of LDL cholesterol and triglycerides, suggesting a broader role in metabolic health beyond diabetes control.